Guidance on Brexit transition period
ABPI response to MHRA guidance for the end of the transition period The MHRA has published information for pharmaceutical companies…
EU
New EU rules for reprocessing Single-Use Devices
EU Commission Publishes Stringent New Common Specifications Requirements for Reprocessing Single-Use Devices, Making In-House Hospital Reprocessing "Difficult if not Impossible"…
EU sugar quotas and the obesity problem
The EU sugar market has long been regulated by quotas which imposed limits on production of beet sugar. However, since…
EU debate on biosimilar drugs
Biosimilar medicines have been the hot subject of debate for a number of years. But as health systems around the…
Brexit and the future of UK medical research
We are now living in a post-Brexit world. On the 23rd June 2016, we as a nation decided to leave…